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Brief Report
The impact of depressive symptoms
on the burden of cluster headache:
Results of the EUROLIGHT Cluster
Headache Project, an Internet-based,
cross-sectional study of people with
cluster headache
Heiko Pohl1 , Andreas R Gantenbein1,2, Peter S Sandor1,2,
Jean Schoenen3, and Colette Andre´e4,5
Abstract
Many patients affected by cluster headache (CH) have a co-morbid depression. The aim of this study is to evaluate how the
burden of disease is influenced by depressive symptoms measured by a depression score. The study was cross-sectional
and Internet-based. We included individuals with a self-reported diagnosis of CH and asked them to fill out the
EUROLIGHT questionnaire, which includes a depression score. The number of headache days was higher among patients
with higher depression scores. In these participants, worrying about future attacks, avoiding triggers, believing to have
earned less and avoiding to talk about the disease were more common as well. Individuals with higher depression scores
reported a significantly higher burden of disease. It is possible that fear of pain, self-concealment and fear of impover-
ishment are consequences of the depression attributed to the headache disorder.
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Introduction
Cluster headache (CH) is a primary headache disorder
characterized by excruciating, half-sided pain accompanied
by autonomic symptoms or a sense of restlessness.1 The
associated burden of disease is tremendous. High individ-
ual healthcare costs and high indirect costs because of
absenteeism are frequent consequences of the disorder.2
Many patients suffering from chronic pain disorders
have a co-morbid depression,3 and CH patients are no
exception in that regard.4 Little is known about whether
and how a co-morbid depression influences the disorder.
The aim of this study is to evaluate how the burden
of disease differs between CH patients in whom psycho-
logical testing suggests a depression and those in whom
it does not.
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Methods
Design and sampling methods are described elsewhere.5,6
The study was designed as cross-sectional and Internet-
based; data were collected anonymously. Participants filled
in the EUROLIGHT questionnaire online. Inclusion cri-
teria were a self-reported diagnosis of CH and a residency
in a European country; exclusion criteria were refusal to
give informed consent and to complete the questionnaire.
No incentives were offered for participation.
The depression subscale of the Hospital Anxiety and
Depression Scale (HADS-D) was included in the question-
naire to determine the magnitude of depressive symptoms.5
Participants indicated the extent of agreement with seven
different statements on a four-point Likert-type scale allo-
cating numerical values ranging from 0 to 3. The total score
is calculated summing up the chosen values and ranges
from 0 to 21. Depression is assumed in patients scoring
eight or more points.7
We performed the analyses at the University Hospital
Zurich using SPSS version 25 (IBM, New York, USA).
Categorical variables are described as proportions and con-
tinuous variables as means and standard deviations. We
used the w2 test to test for associations in contingency
tables; their extents are reported as odds ratio (OR) with
the 95% confidence interval (CI). In addition, the Mann–
Whitney U test was used; effect sizes were calculated as
published8 and interpreted as large effect when r ¼ 0.5, as
medium when r ¼ 0.3, and small when r ¼ 0.1. Signifi-
cance level was set at p < 0.05. We refer to missing data as
‘not reported’ (n.r.).6
Results
The questionnaire was completed by 1514 individuals.5
We were able to confirm the diagnosis of CH in 1165
participants. Most of these participants (1080; 92.7%)
answered all seven questions of the HADS-D; only their
data sets were included in the further analyses. No parti-
cipant from the Czech Republic fulfilled that criteria,
thus, only data sets from 16 countries were included in
further analyses.
Among them, 757 were male (70.1%; 2 n.r.), a majority
of 88.9% (136 n.r.) was either employed or studying and
72.8% were married or living with a partner (22 n.r.). Mean
age was 42.2 + 10.8 years (5 n.r.). Table 1 lists demo-
graphic data. Most of the participants (70.5%, 2 n.r.) had at
least one headache day in the 30 days prior to the survey,
suggesting that they were ‘in bout’.
Of those included in the analysis, 283 participants
(26.7%) reported suffering from chronic CH (22 n.r.) and
the validity of that diagnosis was confirmed in 234
(82.7%). When analysing the data of those suffering from
chronic CH, only data sets fulfilling the criteria for chronic
CH were included.
The median score reached in the HADS-D was 6.0
points. Figure 1 shows the frequency distribution. Eight
or more points were reached by 440 participants (40.7%).
Table 2 provides the differences between patients with
higher and lower scores.
We will refer to symptoms and consequences of the
disease occurring during the pain phase as ictal burden and
to those occurring outside the attack as interictal burden.
Table 1. Numbers of participants and demographic characteristics per country.a
Country Participants, n (%) Sex (% male) Age, mean (SD)
Employed
or student (%)
Married or living
with partner (%)
Austria 34 (3.1) 64.7 38.9 (9.2) 96.7 76.5
Belgium 31 (2.9) 67.7 42.1 (9.0) 92.3 82.8
Czech Republic – – – – –
Denmark 11 (1.0%) 63.6 41.3 (15.7) 80.0 63.6
Finland 48 (4.4) 59.6 42.6 (12.8) 94.6 77.1
France 201 (18.6) 73.6 39.7 (10.2) 85.0 72.1
Germany 256 (23.7) 72.9 43.2 (9.5) 93.2 72.2
Ireland 5 (0.5) 60.0 47.0 (11.6) 100 100
Italy 82 (7.6) 70.7 40.1 (10.2) 92.3 87.8
Luxembourg 1 (0.1) 100 46 100.0 100
Netherlands 15 (1.4) 60.0 40.9 (13.6) 92.3 66.7
Norway 19 (1.8) 68.4 40.8 (11.0) 100.0 84.2
Poland 9 (0.8) 66.7 45.9 (7.6) 77.8 55.6
Spain 92 (8.5) 78.3 39.3 (9.0) 82.7 76.4
Sweden 43 (4.0) 65.1 43.4 (13.7) 86.5 78.0
Switzerland 41 (3.8) 80.5 40.1 (11.3) 94.4 68.3
United Kingdom 192 (17.8) 63.5 42.2 (10.8) 84.4 70.9
Total 1080 70.1 42.2 (10.8) 88.9 72.8
HADS-D: Depression subscale of the Hospital Anxiety and Depression Scale; SD: standard deviation.
aEven though some people from the Czech Republic had participated in the survey,5 none of them had filled out the HADS-D.
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Ictal burden and depression
Participants scoring eight or more points in the HADS-D
reported higher numbers of (i) headache days in the last 30
days (p < 0.001, r¼ 0.25, 2 n.r.), (ii) days absent from work
(p < 0.001, r ¼ 0.37, 501 n.r.) and (iii) days unable to do
any housework (p < 0.001, r ¼ 0.35, 487 n.r.). A higher
HADS-D score was also associated with a higher number of
days on which medication was taken (p ¼ 0.008, r ¼ 0.14,
713 n.r.) and a higher number of attacks per 24 h (p < 0.001,
r ¼ 0.19).
Participants likely to suffer from a co-morbid depression
reported hurting themselves during attacks more frequently
(OR ¼ 2.760, 95% CI: 2.218–3.579; p < 0.001, 31 n.r.) and
suffered from chronic CH more often (OR ¼ 2.637, 95%
CI: 1.957–3.552; p < 0.001, 49 n.r.). A prophylactic treat-
ment was taken by them more frequently (OR ¼ 1.534,
95% CI: 1.202–1.959; p ¼ 0.001).
We found no association between depressive symptoms
and the number of years suffered from the disease (p ¼
0.082, 2 n.r.).
Interictal burden and depression
A HADS-D score of eight or more points was associated
with worrying about future attacks (OR ¼ 2.503, 95% CI:
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Figure 1. Frequency distribution of the HADS score; the vertical black line indicates the cut-off above which the diagnosis of a
depression is assumed. Eight or more points were reached by 40.7% of the participants. HADS: Depression subscale of the Hospital
Anxiety and Depression Scale.
Table 2. Differences between participants with higher and lower scores in the HADS-D.
HADS-D
score <8
HADS-D
score 8 n.r. p Value
Number of participants 640 440 0 –
Suffering from chronic CH 15.7% 33.0% 49 <0.001
Taking preventative drugs 45.9% 56.6% 0 0.001
Having had at least one CH attack during the last 30 days 63.2% 81.3% 2 <0.001
Having hurt oneself during an attack 26.7% 50.1% 31 <0.001
Being anxious or worried about the next headache attack 61.7% 80.1% 58 <0.001
Feeling in control of the headaches ‘always’, ‘often’ or ‘sometimes’ 68.1% 49.0% 10 <0.001
Feeling of family and friends understanding and accepting the headaches 85.3% 66.4% 42 <0.001
Feeling of employer and work colleagues understanding and accepting the headaches 55.8% 32.3% 244 <0.001
Avoiding to tell others about headaches 45.1% 58.3% 28 <0.001
Trying actively to avoid getting a headache 46.1% 61.8% 68 <0.001
Belief of having had a less successful career because of CH 45.3% 78.0% 25 <0.001
Belief of headaches having resulted in reduced earnings 26.8% 65.1% 92 <0.001
Having had less or no children because of CH 9.6% 24.9% 43 <0.001
CH caused a relationship break-down 7.0% 22.3% 74 <0.001
HADS-D: Depression subscale of the Hospital Anxiety and Depression Scale; n.r.: not reported; CH: cluster headache.
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1.871–3.348; p < 0.001, 58 n.r.) and trying to avoid poten-
tial triggers (OR ¼ 1.887, 95% CI: 1.462–2.435; p < 0.001,
68 n.r.). Also, participants with a higher score avoided
talking to others about their disease more frequently
(OR ¼ 1.701, 95% CI: 1.326–2.182; p < 0.001, 28 n.r.).
Participants in whom psychological testing suggested a
depression often believed having earned less because of
their disease (OR ¼ 5.095, 95% CI: 3.869–6.708; p <
0.001, 92 n.r.) and felt having had their career impaired
by the disease (OR ¼ 4.291, 95% CI: 3.251–5.665; p <
0.001, 25 n.r.).
Scoring eight or more points in the HADS-D was asso-
ciated with more frequent reports of having had a broken
relationship because of the disease (OR ¼ 3.822, 95% CI:
2.584–5.653; p < 0.001, 74 n.r.) and having had less or no
children because of the disease (OR ¼ 3.274, 95% CI:
2.257–4.747; p < 0.001, 63 n.r.).
A feeling of being understood by colleagues and
employers or by family and friends was less common
among those found likely to be depressed by the test (OR
¼ 0.369, 95% CI: 0.276–0.493; p < 0.001, 244 n.r.; OR ¼
0.340, 95% CI: 0.251–0.459, p < 0.001, 42 n.r., respec-
tively). Having felt symptom-free on the last headache-
free day was reported less frequently by those who scored
more than eight points (OR¼ 0.605, 95% CI: 0.468–0.786,
p < 0.001, 76 n.r.). A report of having the CH ‘rarely’ and
‘never’ as opposed to ‘always’, ‘often’ or ‘sometimes’
under control was associated with a higher score (OR ¼
2.223, 95% CI: 1.729–2.858; p < 0.001, 10 n.r.) as well.
Discussion
We evaluated a large data set of CH patients from 16 Eur-
opean countries to study whether the presence of a co-
morbid depression is associated with changes in the burden
of disease. The main finding of the analyses is that both
ictal and interictal burden are reported to be significantly
higher by individuals with suspected depression.
Patients with higher scores in the HADS-D recounted
higher numbers of headache days as well as higher numbers
of days impaired by the disorder. This might be the reason
for prophylactic treatment being more common in that sub-
group. However, since headache frequency was assessed
retrospectively, a recall bias must be expected. Interest-
ingly, one study found that depressed children and adoles-
cents underestimate the number of headache attacks.9 If
depressed adults underestimated their headache frequency,
too, depression might indeed be associated with a consid-
erably higher number of CH attacks.
In a prospective study, investigators observed that the risk
of depression increases with the number of bouts per year.4 It
is unknown, however, whether depressions have an influ-
ence on the number of attacks, as well. A mutual influence
may be suspected as depressions reduce the pain threshold in
an experimental setting.10 This study being cross-sectional,
no conclusions about causality may be derived.
Having a higher HADS-D score was associated with not
feeling symptom-free on days without pain. We did not
evaluate what exactly these participants experienced, but
one might speculate that depressive symptoms were
referred to. For example, worrying thoughts were more
common in those with higher depression scores. In addi-
tion, believing not to be in control of the disorder was stated
often and might be indicative of a feeling of helplessness.
Those with higher HADS-D scores often avoided to
discuss their disease with others. One wonders whether
the reported lacking understanding of colleagues, employ-
ers, families and friends was a consequence of not talking
to them. We do not know whether these participants had
never wanted to share any details about their disease or
were actively hiding them. The latter has been termed
self-concealment. It is defined as ‘active concealment
from others of personal information that one perceives
as negative or distressing’ and is more common in people
with depression.11
Avoidance of potential triggers was indicated more fre-
quently by participants with higher scores in the depression
scale. Searching for potential triggers and trying to avoid
them suggests a coexisting fear of pain that is often associ-
ated with depression and may lead to increased disability.12
The feeling of having had reduced earnings and an
impaired career was significantly associated with higher
scores in the HADS-D. It is possible that these participants
had been unable to earn money because of their headache
disorder or a depression. However, we need to consider that
this feeling may be a symptom of the depression as well, as
the fear of impoverishment has been described as one type
of depressive delusion.13
The study’s strengths are the large sample size and the
large number of countries involved.5 Some limitations
should be noted: Even though a higher HADS-D score sug-
gests depression and measures the extent of depressive
symptoms, it cannot prove the clinical diagnosis. Despite the
large number of participants, the estimated participation rate
was low. In addition, it is likely that women and those
severely affected by CH were over-represented.5 Finally, the
sample is not population-based and statistical correction of
the sampling bias was not possible as information on non-
participants was unavailable. Because of these latter limita-
tions, we did not draw conclusions about incidence and
prevalence. Instead, we narrowed the analysis to the inves-
tigation of relationships between subgroups and influencing
factors. Given that demographic data did not suggest one
subgroup having been completely missed, these conclusions
are less likely to be affected by the sampling error.6
Conclusions
Depression is a frequent co-morbidity in CH, but to date,
little is known about how these disorders interact. In this
article, we studied the impact of depression on the burden
of disease.
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Overall, both ictal and interictal burden were consider-
ably higher in participants with suspected depression.
While previous research had shown that depression may
be a direct consequence of an increased ictal burden,4 this
study adds that the attack frequency remains high in the
presence of a depression. In addition, it is likely that inter-
ictal burden, such as fear of pain, self-concealment and fear
of impoverishment, might be consequences of the depres-
sion rather than the headache disorder itself.
This study highlights that pain is not the only burden that
patients suffering from CH are confronted with. We wish to
encourage screening every patient suffering from CH for
depression. Furthermore, we propose that screening for and
– if needed – treatment of mood disorders be mentioned in
treatment guidelines. Prospective research is needed tounder-
stand how treating depression influences the burden of CH.
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